Login to Your Account



Genzyme Beats Estimates With Product Sales, Curbed Expenses

By Brady Huggett


Thursday, October 21, 2004
Genzyme Corp. reported third-quarter numbers that beat consensus estimates, and the diversification plans the company put in place over the past year are taking hold, it said. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription